Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.10 -0.11 (-2.11%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atea Pharmaceuticals (AVIR) Preferred Stock Liabilities (2019 - 2020)

Updated

Atea Pharmaceuticals (AVIR) recorded Preferred Stock Liabilities of $175.75 million in Q3 2020, up 154.3% from $69.11 million a year earlier and unchanged from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Atea Pharmaceuticals reported Preferred Stock Liabilities of $69.11 million, unchanged from FY2018.

  • Across earlier years, Preferred Stock Liabilities came in at $69.11 million in FY2018.
  • Per Business Quant, the preceding three quarters came in at $175.75 million (Q2 2020), $69.11 million (Q1 2020) and $69.11 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Atea Pharmaceuticals 417.87 Mn 417.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 175.75 Mn
Jun 30, 2020 175.75 Mn
Mar 31, 2020 69.11 Mn
Dec 31, 2019 69.11 Mn
Sep 30, 2019 69.11 Mn
API Access

Atea Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=AVIR&period=max&api_key=YOUR_API_KEY